Strata Critical Medical Reports Q3 Earnings Per Share of 70 Cents Compared to (3 Cents) Last Year
Reports Q3 revenue $49.298M vs $36.062M last year. "We closed two transformational transactions during the quarter, the divestiture of our Passenger business and the acquisition of Keystone Perfusion, setting us up incredibly well for long term growth and value creation," said Melissa Tomkiel, Co-CEO and General Counsel. "Organic revenue growth accelerated to 29.0% in Q3, well above our expectation for mid-teens revenue growth in the second half of the year, resulting in record Adjusted EBITDA performance."
